Literature DB >> 15890012

Role of oxidative damage in protein aggregation associated with Parkinson's disease and related disorders.

Erin H Norris1, Benoit I Giasson.   

Abstract

Parkinson's disease, the most common movement disorder, is characterized by the loss of brainstem neurons, specifically dopaminergic neurons in the substantia nigra, as well as the accumulation of neuronal cytoplasmic filamentous proteinaceous inclusions comprised of polymerized alpha-synuclein. It was reported recently that alpha-synuclein can induce the formation of filamentous tau inclusions, which are characteristic of disorders like Alzheimer's disease and Lewy body variant of Alzheimer's disease, suggesting that a similar mechanism may exist between alpha-synuclein fibrillogenesis and tau polymerization. Pathological brain inclusions comprised of alpha-synuclein or tau proteins are associated with a spectrum of neurodegenerative disorders, and oxidative and nitrative injury has been implicated in all of these diseases. However, the role of oxidative damage in alpha-synuclein and tau polymerization and pathological inclusion formation is complex. Differences in the level, type, and temporal sequence of the oxidative alterations appear to result in both inhibitory and stimulatory effects on the fibrillogenesis of these proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15890012     DOI: 10.1089/ars.2005.7.672

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  13 in total

1.  Head injury, α-synuclein Rep1, and Parkinson's disease.

Authors:  Samuel M Goldman; Freya Kamel; G Webster Ross; Sarah A Jewell; Grace S Bhudhikanok; David Umbach; Connie Marras; Robert A Hauser; Joseph Jankovic; Stewart A Factor; Susan Bressman; Kelly E Lyons; Cheryl Meng; Monica Korell; Diana F Roucoux; Jane A Hoppin; Dale P Sandler; J William Langston; Caroline M Tanner
Journal:  Ann Neurol       Date:  2012-01       Impact factor: 10.422

2.  Pesticide exposure exacerbates alpha-synucleinopathy in an A53T transgenic mouse model.

Authors:  Erin H Norris; Kunihiro Uryu; Susan Leight; Benoit I Giasson; John Q Trojanowski; Virginia M-Y Lee
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

Review 3.  Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention.

Authors:  Malú G Tansey; Melissa K McCoy; Tamy C Frank-Cannon
Journal:  Exp Neurol       Date:  2007-07-17       Impact factor: 5.330

4.  The unintended mitochondrial uncoupling effects of the FDA-approved anti-helminth drug nitazoxanide mitigates experimental parkinsonism in mice.

Authors:  Niharika Amireddy; Srinivas N Puttapaka; Ravali L Vinnakota; Halley G Ravuri; Swaroop Thonda; Shasi V Kalivendi
Journal:  J Biol Chem       Date:  2017-08-10       Impact factor: 5.157

5.  Lewy bodies.

Authors:  Clifford W Shults
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-31       Impact factor: 11.205

Review 6.  Redox regulation of autophagy in healthy brain and neurodegeneration.

Authors:  Kenneth Hensley; Marni E Harris-White
Journal:  Neurobiol Dis       Date:  2015-03-11       Impact factor: 5.996

7.  Peroxidase mechanism of lipid-dependent cross-linking of synuclein with cytochrome C: protection against apoptosis versus delayed oxidative stress in Parkinson disease.

Authors:  Hülya Bayir; Alexandr A Kapralov; Janfei Jiang; Zhentai Huang; Yulia Y Tyurina; Vladimir A Tyurin; Qing Zhao; Natalia A Belikova; Irina I Vlasova; Akihiro Maeda; Jianhui Zhu; Hye-Mee Na; Pier-Giorgio Mastroberardino; Louis J Sparvero; Andrew A Amoscato; Charleen T Chu; John T Greenamyre; Valerian E Kagan
Journal:  J Biol Chem       Date:  2009-04-07       Impact factor: 5.157

8.  Mitochondrial inhibitor 3-nitroproprionic acid enhances oxidative modification of alpha-synuclein in a transgenic mouse model of multiple system atrophy.

Authors:  Kiren Ubhi; Phil Hyu Lee; Anthony Adame; Chandra Inglis; Michael Mante; Edward Rockenstein; Nadia Stefanova; Gregor K Wenning; Eliezer Masliah
Journal:  J Neurosci Res       Date:  2009-09       Impact factor: 4.164

Review 9.  Ageing and neuronal vulnerability.

Authors:  Mark P Mattson; Tim Magnus
Journal:  Nat Rev Neurosci       Date:  2006-04       Impact factor: 34.870

10.  Dopamine-induced conformational changes in alpha-synuclein.

Authors:  Tiago F Outeiro; Jochen Klucken; Kathryn Bercury; Julie Tetzlaff; Preeti Putcha; Luis M A Oliveira; Alexandre Quintas; Pamela J McLean; Bradley T Hyman
Journal:  PLoS One       Date:  2009-09-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.